Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Tamoxifen × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 245 Carcinoma, Intraductal, Noninfiltrating 21 Breast Carcinoma In Situ 17 Neoplasm Metastasis 14 Neoplasms 12 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 4 Breast Cancer Female 4 Recurrence 3 Prostatic Neoplasms 3 Obesity 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Pancreatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Astrocytoma 2

Interventions

Endoscopy 15 Endoscopy, Digestive System 12 Biopsy 9 Endoscopic Mucosal Resection 8 Radiofrequency Ablation 7 Esomeprazole 7 Specimen Handling 6 Gastroscopy 6 Omeprazole 4 Aspirin 4 Proflavine 3 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 omeprazole, sodium bicarbonate drug combination 1 obeticholic acid 1 gluconic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02089386 2017-03-13

Tamoxifen to Treat Barrett's Metaplasia

Washington University School of Medicine

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡